Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 15901-15950 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05038852
Acceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot Study
NAActive, not recruiting
8 participants
Started: Apr 12, 2019 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03753685
X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases
PHASE2Active, not recruiting
27 participants
Started: Apr 12, 2019 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT03872180
Bendamustine, Obinutuzumab, and Venetoclax in Patients With Untreated Mantle Cell Lymphoma
PHASE2Active, not recruiting
23 participants
Started: Apr 11, 2019 · Completed: Apr 30, 2026
3 conditions4 sponsors3 locations
NCT03718052
Early Valve Surgery Versus Conventional Treatment in Infective Endocarditis Patients With High Risk of Embolism
NAActive, not recruiting
73 participants
Started: Apr 11, 2019 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT03776552
Effectiveness of Gradual Versus Rapid Weight Loss
NAActive, not recruiting
293 participants
Started: Apr 11, 2019 · Completed: Dec 31, 2028
1 condition2 sponsors1 location
NCT03877796
Clinical Pre-screening Protocol for Ovarian Cancer
N/AActive, not recruiting
60 participants
Started: Apr 11, 2019 · Completed: Dec 31, 2026
1 condition2 sponsors5 locations
NCT03889912
Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma
PHASE1Active, not recruiting
97 participants
Started: Apr 11, 2019 · Completed: Feb 2, 2026
2 conditions1 sponsor18 locations
NCT02988271
Meditation Therapy in Improving Anxiety and Depression in Cancer Patients With Psychosocial Distress
NAActive, not recruiting
35 participants
Started: Apr 11, 2019 · Completed: Feb 28, 2026
3 conditions2 sponsors1 location
NCT04064593
Sleep Disordered Breathing (SDB) Prevalence and Cardiovascular Outcomes of Myocardial Infarction (MI) Survivors
NAActive, not recruiting
2,007 participants
Started: Apr 11, 2019 · Completed: Sep 30, 2024
2 conditions2 sponsors1 location
NCT03744793
Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer
PHASE2Active, not recruiting
18 participants
Started: Apr 11, 2019 · Completed: Jan 31, 2027
7 conditions2 sponsors1 location
NCT03763253
Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms
PHASE2Active, not recruiting
433 participants
Started: Apr 10, 2019 · Completed: Jan 31, 2027
2 conditions2 sponsors21 locations
NCT03920358
FRED/ FRED Jr/ FRED X Intracranial Aneurysm Treatment Study
N/AActive, not recruiting
156 participants
Started: Apr 10, 2019 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT03726307
Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study
PHASE1Active, not recruiting
28 participants
Started: Apr 10, 2019 · Completed: Mar 31, 2027
2 conditions2 sponsors1 location
NCT03906279
Choroidal Thickness Change in Response to Physiological and Refractive Changes
N/AActive, not recruiting
250 participants
Started: Apr 10, 2019 · Completed: Feb 28, 2026
2 conditions2 sponsors1 location
NCT03868670
Responsive Neurostimulation For Loss Of Control Eating
NAActive, not recruiting
6 participants
Started: Apr 10, 2019 · Completed: Jan 1, 2026
2 conditions2 sponsors2 locations
NCT03865511
MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtib
PHASE2Active, not recruiting
150 participants
Started: Apr 9, 2019 · Completed: Jan 31, 2025
1 condition2 sponsors17 locations
NCT03682848
Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected Adolescents
PHASE3Active, not recruiting
32 participants
Started: Apr 9, 2019 · Completed: Sep 30, 2024
1 condition1 sponsor8 locations
NCT03647163
Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors
PHASE1/PHASE2Active, not recruiting
33 participants
Started: Apr 9, 2019 · Completed: Sep 30, 2025
4 conditions2 sponsors2 locations
NCT03831334
Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia
EARLY_PHASE1Active, not recruiting
14 participants
Started: Apr 9, 2019 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT03854032
Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck
PHASE2Active, not recruiting
45 participants
Started: Apr 9, 2019 · Completed: Dec 31, 2025
5 conditions2 sponsors2 locations
NCT03937973
Social Experiences and Sleep Study
NAActive, not recruiting
139 participants
Started: Apr 9, 2019 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT03934866
The SUMMIT Study: A Cancer Screening Study
N/AActive, not recruiting
13,035 participants
Started: Apr 8, 2019 · Completed: Aug 31, 2030
2 conditions3 sponsors1 location
NCT03987399
Pediatric Postoperative Pain Management in Surgical Wards - an Intervention Study
NAActive, not recruiting
650 participants
Started: Apr 8, 2019 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT03899090
Floatation-REST (Reduced Environmental Stimulation Therapy) for Anxiety and Depression
NAActive, not recruiting
75 participants
Started: Apr 8, 2019 · Completed: May 31, 2024
6 conditions2 sponsors1 location
NCT03882060
Effect of Recombinant Human EPO on the Postoperative Neurologic Outcome in Pediatric Moyamoya Patients
NAActive, not recruiting
60 participants
Started: Apr 8, 2019 · Completed: Dec 31, 2023
3 conditions1 sponsor1 location
NCT03945318
Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)
PHASE1/PHASE2Active, not recruiting
103 participants
Started: Apr 8, 2019 · Completed: Apr 13, 2026
1 condition1 sponsor16 locations
NCT05645237
HRQOL in Prostate Cancer Patients Treated With Radiotherapy
N/AActive, not recruiting
600 participants
Started: Apr 8, 2019 · Completed: Jun 1, 2030
1 condition2 sponsors1 location
NCT03851614
Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors
PHASE2Active, not recruiting
90 participants
Started: Apr 8, 2019 · Completed: Jan 1, 2026
3 conditions2 sponsors1 location
NCT03869372
Cerebral Cortical Influences on Autonomic Function
NAActive, not recruiting
244 participants
Started: Apr 5, 2019 · Completed: Oct 3, 2025
3 conditions2 sponsors1 location
NCT03793179
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer
PHASE3Active, not recruiting
600 participants
Started: Apr 5, 2019 · Completed: Sep 30, 2027
4 conditions1 sponsor1099 locations
NCT06755164
Effects of Combined Aerobic and Cognitive Training in a Simultaneous or Sequential Paradigm on Cognition and Brain Functional Activity in Patients with AMCI
NAActive, not recruiting
55 participants
Started: Apr 5, 2019 · Completed: Feb 28, 2025
4 conditions1 sponsor1 location
NCT03199885
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
PHASE3Active, not recruiting
190 participants
Started: Apr 5, 2019 · Completed: May 15, 2025
8 conditions2 sponsors673 locations
NCT03849716
Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)
N/AActive, not recruiting
266 participants
Started: Apr 5, 2019 · Completed: Sep 30, 2026
1 condition1 sponsor48 locations
NCT03775096
Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)
PHASE2Active, not recruiting
15 participants
Started: Apr 4, 2019 · Completed: Jul 1, 2026
3 conditions1 sponsor1 location
NCT03898479
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
PHASE2/PHASE3Active, not recruiting
1,000 participants
Started: Apr 4, 2019 · Completed: Jun 30, 2027
1 condition1 sponsor91 locations
NCT03448003
Comprehensive Lifestyle Change To Prevent Breast Cancer
NAActive, not recruiting
60 participants
Started: Apr 4, 2019 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT03598530
Fracture-Related Outcome Study for Operatively Treated Tibia Shaft Fractures
N/AActive, not recruiting
1,000 participants
Started: Apr 4, 2019 · Completed: Dec 31, 2025
2 conditions2 sponsors15 locations
NCT03913143
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
PHASE2/PHASE3Active, not recruiting
36 participants
Started: Apr 4, 2019 · Completed: Mar 31, 2023
10 conditions1 sponsor14 locations
NCT03860805
SALpingectomy for STERilization (SALSTER)
NAActive, not recruiting
900 participants
Started: Apr 3, 2019 · Completed: Dec 31, 2050
4 conditions2 sponsors1 location
NCT03690089
Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United Kingdom
PHASE2Active, not recruiting
289 participants
Started: Apr 3, 2019 · Completed: Feb 2, 2027
1 condition1 sponsor4 locations
NCT03840421
GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE3Active, not recruiting
468 participants
Started: Apr 3, 2019 · Completed: Dec 31, 2028
4 conditions4 sponsors1 location
NCT03580083
RGX-111 Gene Therapy in Patients With MPS I
PHASE1/PHASE2Active, not recruiting
8 participants
Started: Apr 3, 2019 · Completed: Oct 31, 2024
3 conditions1 sponsor4 locations
NCT04005430
A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema
PHASE1Active, not recruiting
1 participants
Started: Apr 3, 2019 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT03650894
Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients
PHASE2Active, not recruiting
30 participants
Started: Apr 3, 2019 · Completed: Dec 31, 2026
4 conditions3 sponsors2 locations
NCT04191655
High Definition Colonoscopy (HDC) vs. Dye Spraying Chromo-colonoscopy (DSC) in Screening Patients With Long-standing Inflammatory Bowel Disease (IBD)
NAActive, not recruiting
500 participants
Started: Apr 3, 2019 · Completed: Dec 31, 2025
5 conditions1 sponsor2 locations
NCT03908099
Fit-for-Fertility Multicenter Randomized Controlled Trial
NAActive, not recruiting
408 participants
Started: Apr 3, 2019 · Completed: Dec 31, 2029
2 conditions3 sponsors5 locations
NCT03759015
Evaluation of Health Education Theater
NAActive, not recruiting
10 participants
Started: Apr 3, 2019 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT03808610
Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia
PHASE1/PHASE2Active, not recruiting
50 participants
Started: Apr 3, 2019 · Completed: Dec 31, 2026
4 conditions2 sponsors1 location
NCT03889613
Pillcam Crohn's Capsule for Monitoring of Panenteric Mucosal Healing in Crohn's Disease Patients With Vedolizumab
NAActive, not recruiting
60 participants
Started: Apr 3, 2019 · Completed: Nov 1, 2024
1 condition3 sponsors1 location
NCT03744390
IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
PHASE2Active, not recruiting
68 participants
Started: Apr 2, 2019 · Completed: Mar 18, 2026
2 conditions1 sponsor22 locations